Lymph & Co Research Grant 2018

Lymph & Co Call for proposals


Lymph&Co Research Grant

‘Lymph & Co supports groundbreaking scientific research to cure lymphoma’


1. Aim of the call

Every year about 500,000 new patients are diagnosed with malignant lymphoma worldwide. While a progressively increasing proportion of patients can currently be cured with various modern modalities of treatment due to scientific progress, unfortunately there is still a significant proportion of patients in whom cure cannot be attained. Thus in too many patients the treatment of malignant lymphoma poses a big unmet therapeutic need.

Therefore, Lymph & Co works with the motto “Away with Lymphoma”.

To achieve this goal, innovative scientific research will be a necessity in order to make breakthroughs in the treatment of patients with malignant lymphoma. Lymph & Co has linked itself to a strong commitment to stimulate promising and high quality research and to offer financial support for programs that open new perspectives on therapy that may pave the way for better outcome and/or more cure.

Any promising research project that is relevant, impactful, and of high quality is eligible for funding.


2. Call Topic

The focus of the call is on the therapeutics of malignant lymphoma, malignant lymphoid neoplasia and related malignant blood diseases (particularly lymphoid disorders). Projects will be considered that enhance our understanding of the origin and biology of these disorders and projects that furnish insights or develop tools that will advance the treatment.


3. Application

3.1 Eligibility

Not only applications from individual researchers or research groups are welcomed but in particular also cooperative proposals from scientific groups (national and/or international) with complementing expertise.

3.2 Submission of proposal (use Lymph & Co application form)

Time line

September 1st, 2018

  Publication of the Lymph & Co Call

October 1st, 2018 (17:00 CET)

  Submission deadline for pre-proposals to

October 17th, 2018

  Full proposal invitations sent to project coordinators

December 15th, 2018 (17:00 CET)

  Submission deadline for full proposals

By March 15th, 2019

  Final funding decision to applicants

By April/May 1st, 2019

  Start of funding














3.3 Financial modalities and funding prerequisites

Applications for funding for personnel and materials/infrastructure have a maximum of Eur 1.500.000,00. Funding is granted for a maximum of four years.

The applicants should agree that scientific data obtained during the research will be made public so that they will also become available to other scientists. Applications should also be willing to present their research project to donors of Lymph & Co and/or other interested parties.


3.4 Contact details

The only official communication line of the proposal is between the Lymph & Co Secretariat ( and the project coordinator. The project coordinator will be the person contacted by the Secretariat during the application procedure, so he/she must forward this information to the other participants.


4. Evaluation

Proposals will be assessed according to specific evaluation criteria (see below).

Evaluation criteria:

  1. Excellence  
    a. Clarity and pertinence of the objectives;
    b. Soundness of the concept;
    c. Innovative potential;
    d. Competence and experience of participating research partners in the field(s) of the proposal 
        (previous work in the field, specific technical expertise). 

  2. Impact
    a. Potential of the expected results for the future clinical applications including patients’ needs
    b. Effctiveness of the proposed measures to exploit and disseminate the project results 
        (including managementof IPR), to communicate the project to the patients and to 
        manage research data where relevant
    c. Industry and Patient Organization participation/engagement (when appropriate/applicable)
    d. Competence and experience of participating research partners in the field(s) of the proposal
        (previous work in the field, specific technical expertise)

  3. Quality and efficiency of the implementation
    a. Coherence and effectiveness of the work plan, including appropriateness of the allocation of 
        tasks, resources and time frame
    b. Budget and cost-effectiveness of the project (rational distribution of resources in relation to 
        project’s activities, partners responsibilities and time frame)




Call for research proposals Lymph&Co 2018 Call for research proposals Lymph&Co 2018 Call for research proposals
Preproposal grant application form Lymph&Co 2018 Preproposal grant application form